Research Triangle Park, NC, August 4,1997 -- Lineberry Research Associates (LRA), a pharmaceutical research and consulting firm located in Research Triangle Park, NC, announced today the addition of Susan Locke, Ph.D., as Clinical Research Scientist, Ruth Kay as Clinical Research Associate, and Florence Bobo as Clinical Research Coordinator

"All three individuals come to LRA with a proven track record of success and expertise in their given areas. Our clients have come to expect satisfaction and quality that exceeds industry standards. These individuals will help us continue to meet the expectations of our clients, by expanding our current capabilities and by bringing their talents and diversity of experience to the LRA team." said Mark Cierpial, Ph.D., Associate Director of Clinical Research and Regulatory Affairs.

Susan Locke has a Ph.D. in neuropharmacology from Duke University with previous experience in medical/scientific writing. Dr. Locke is the author of numerous publications in peer reviewed journals and has presented her work at national and international conferences.

Ruth Kay is a graduate of the University of North Carolina, Chapel Hill. Ms. Kay comes to LRA from Glaxo Wellcome, where she worked as a Clinical Research Coordinator.

Florence Bobo has over 16 years of experience in clinical research. Ms. Bobo also comes to LRA from Glaxo Wellcome, where she most recently worked as a Clinical Research Coordinator III.

Lineberry Research Associates is a full-service contract research organization that provides complete development capabilities, from IND application to NDA approval and post-marketing. In addition to managing clinical trials, LRA differentiates itself by providing its pharmaceutical, biotechnology and related clients with high level scientific and regulatory consulting services and proven expertise in scientific writing and communications.

###